Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer

Cancer Biology and Therapy

Volumn 10, Issue 3, 2010, Pages 267-272

  Khattar, Nada H ^a   Coe atkinson, Sarah P ^a   Stromberg, Arnold J ^b   Jett, James R ^c   Hirschowitz, Edward A ^a,d  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c MAYO CLINIC   (United States)

^d LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Lung cancer; M13 phage; Microarray; Peptide library

Indexed keywords

AMINO ACID; AUTOANTIBODY; BIOLOGICAL MARKER; CANCER ANTIBODY; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY;

AGED; ARTICLE; BACTERIOPHAGE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA LIBRARY; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 77955489097     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.3.12395     Document Type: Article

References (23)

1. Hoffman PC, Mauer Am, Vokes EE. Lung Cancer. Lancet 2000; 355:579-85.
2. Iyengar P, Tsao MS. Clinical relevance of molecular markers in lung cancer. Surg Oncol 2002; 11:167-79. (Pubitemid 35356566)
3. Conrads TP, Hood BL, Petricoin EF, 3rd, Liotta LA, Veenstra TD. Cancer proteomics: many technologies, one goal. Expert Rev Proteomics 2005; 2:693-703.
4. Niklinski J, Furman M. Clinical tumour markers in lung cancer. Eur J Cancer Prev 1995; 4:129-38.
5. Ferrigno D, Buccheri G, Biggi A. Serum tumour markers in lung cancer: history, biology and clinical applications. Eur Respir J 1994; 7:186-97. (Pubitemid 24075144)
6. Buccheri G, Violante B, Sartoris AM, Ferrigno D, Curcio A. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma. Cancer 2001; 34:65-9.
7. Lombardi C, Tassi GF, Pizzocolo G, Donato F. Clinical significance of a multiple biomarker assay in patients with lung cancer. A study with logistic regression analysis. Chest 1990; 97:639-44.
8. Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001; 60:433-41.
9. Stockert E, Jäger E, Chen YT, Scanlan MJ, Gout I, Karbach J, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens 1998; 187:1349-54.
10. Sioud M, Hansen MH. Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries. Eur J Immunol 2001; 31:716-25.
11. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002; 8:295-301.
12. Tureci O, Sahin U, Zwick C, Neumann F, Pfreundschuh M. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma 1999; 18:23-8. (Pubitemid 29140417)
13. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005; 353:1224-35.
14. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, et al. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006; 66:1181-90.
15. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005; 172:1308-14.
16. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling Tumor-Associated Antibodies for Early Detection of Non-Small Cell Lung Cancer. J Thoracic Oncol 2006; 1:513-9.
17. Chen G, Wang X, Yu J, Varambally S, Yu J, Thomas DG, et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 2007; 67:3461-7.
18. Molinaro AM, Simon R, Pfeiffer RM. Prediction error estimation: a comparison of resampling methods. Bioinformatics 2005; 21:3301-7. (Pubitemid 41418445)
19. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 2001; 21:45-56.
20. Katz MH. Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003; 138:644-50.
21. Tanguay S, Bégin LR, Elhilali MM, Behlouli H, Karakiewicz PI, Aprikian AG. Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 2002; 59:261-5.
22. Ozdal OL, Aprikian AG, Begin LR, Behlouli H, Tanguay S. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer. Br J Urol 2004; 93:970-4.
23. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, et al. Screening for Lung Cancer with Low-Dose Spiral Computed Tomography. Am J Respir Crit Care Med 2002; 165:508-13.